150 related articles for article (PubMed ID: 32589198)
1. Visual Field Progression in Retinitis Pigmentosa.
Xu M; Zhai Y; MacDonald IM
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):56. PubMed ID: 32589198
[TBL] [Abstract][Full Text] [Related]
2. Quantification of the Visual Field Loss in Retinitis Pigmentosa Using Semi-Automated Kinetic Perimetry.
Nowomiejska K; Brzozowska A; Koss MJ; Weleber RG; Schiefer U; Rejdak K; Juenemann AG; Maciejewski R; Rejdak R
Curr Eye Res; 2016 Jul; 41(7):993-8. PubMed ID: 26470834
[TBL] [Abstract][Full Text] [Related]
3. Disease course of patients with X-linked retinitis pigmentosa due to RPGR gene mutations.
Sandberg MA; Rosner B; Weigel-DiFranco C; Dryja TP; Berson EL
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1298-304. PubMed ID: 17325176
[TBL] [Abstract][Full Text] [Related]
4. High Symmetry of Visual Acuity and Visual Fields in RPGR-Linked Retinitis Pigmentosa.
Bellingrath JS; Ochakovski GA; Seitz IP; Kohl S; Zrenner E; Hanig N; Prokisch H; Weber BH; Downes SM; Ramsden S; MacLaren RE; Fischer MD
Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4457-4466. PubMed ID: 28863407
[TBL] [Abstract][Full Text] [Related]
5. Longevity of visual improvements following transcorneal electrical stimulation and efficacy of retreatment in three individuals with retinitis pigmentosa.
Bittner AK; Seger K
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):299-306. PubMed ID: 29222719
[TBL] [Abstract][Full Text] [Related]
6. Reduced Central Retinal Artery Blood Flow Is Related to Impaired Central Visual Function in Retinitis Pigmentosa Patients.
Kayser S; Vargas P; Mendelsohn D; Han J; Bi H; Benavente A; Bittner AK
Curr Eye Res; 2017 Nov; 42(11):1503-1510. PubMed ID: 28910168
[TBL] [Abstract][Full Text] [Related]
7. Vision test variability in retinitis pigmentosa and psychosocial factors.
Bittner AK; Ibrahim MA; Haythornthwaite JA; Diener-West M; Dagnelie G
Optom Vis Sci; 2011 Dec; 88(12):1496-506. PubMed ID: 21946786
[TBL] [Abstract][Full Text] [Related]
8. Wide-field fundus autofluorescence imaging to evaluate retinal function in patients with retinitis pigmentosa.
Ogura S; Yasukawa T; Kato A; Usui H; Hirano Y; Yoshida M; Ogura Y
Am J Ophthalmol; 2014 Nov; 158(5):1093-8. PubMed ID: 25062603
[TBL] [Abstract][Full Text] [Related]
9. CLINICAL CHARACTERISTICS AND NATURAL HISTORY OF RHO-ASSOCIATED RETINITIS PIGMENTOSA: A Long-Term Follow-Up Study.
Nguyen XT; Talib M; van Cauwenbergh C; van Schooneveld MJ; Fiocco M; Wijnholds J; Ten Brink JB; Florijn RJ; Schalij-Delfos NE; Dagnelie G; van Genderen MM; de Baere E; Meester-Smoor MA; De Zaeytijd J; Balikova I; Thiadens AA; Hoyng CB; Klaver CC; van den Born LI; Bergen AA; Leroy BP; Boon CJF
Retina; 2021 Jan; 41(1):213-223. PubMed ID: 32301896
[TBL] [Abstract][Full Text] [Related]
10. Rate of visual field loss in retinitis pigmentosa.
Grover S; Fishman GA; Anderson RJ; Alexander KR; Derlacki DJ
Ophthalmology; 1997 Mar; 104(3):460-5. PubMed ID: 9082273
[TBL] [Abstract][Full Text] [Related]
11. Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa.
Pierrache LH; Hartel BP; van Wijk E; Meester-Smoor MA; Cremers FP; de Baere E; de Zaeytijd J; van Schooneveld MJ; Cremers CW; Dagnelie G; Hoyng CB; Bergen AA; Leroy BP; Pennings RJ; van den Born LI; Klaver CC
Ophthalmology; 2016 May; 123(5):1151-60. PubMed ID: 26927203
[TBL] [Abstract][Full Text] [Related]
12. Genotypic and Phenotypic Characteristics of CRB1-Associated Retinal Dystrophies: A Long-Term Follow-up Study.
Talib M; van Schooneveld MJ; van Genderen MM; Wijnholds J; Florijn RJ; Ten Brink JB; Schalij-Delfos NE; Dagnelie G; Cremers FPM; Wolterbeek R; Fiocco M; Thiadens AA; Hoyng CB; Klaver CC; Bergen AA; Boon CJF
Ophthalmology; 2017 Jun; 124(6):884-895. PubMed ID: 28341475
[TBL] [Abstract][Full Text] [Related]
13. Test-retest, within-visit variability of Goldmann visual fields in retinitis pigmentosa.
Bittner AK; Iftikhar MH; Dagnelie G
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8042-6. PubMed ID: 21896857
[TBL] [Abstract][Full Text] [Related]
14. Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results.
Arslan U; Özmert E; Demirel S; Örnek F; Şermet F
Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):893-908. PubMed ID: 29546474
[TBL] [Abstract][Full Text] [Related]
15. Disease progression of retinitis pigmentosa caused by
Lisbjerg K; Bertelsen M; Lyng Forman J; Grønskov K; Prener Holtan J; Kessel L
Ophthalmic Genet; 2023 Apr; 44(2):139-146. PubMed ID: 36164253
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic Features of Oguchi Disease and Retinitis Pigmentosa in Patients with S-Antigen Mutations: A Long-Term Follow-up Study.
Nishiguchi KM; Ikeda Y; Fujita K; Kunikata H; Akiho M; Hashimoto K; Hosono K; Kurata K; Koyanagi Y; Akiyama M; Suzuki T; Kawasaki R; Wada Y; Hotta Y; Sonoda KH; Murakami A; Nakazawa M; Nakazawa T; Abe T
Ophthalmology; 2019 Nov; 126(11):1557-1566. PubMed ID: 31257036
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical course of 2 Japanese patients with PRPF31-related retinitis pigmentosa.
Kurata K; Hosono K; Hotta Y
Jpn J Ophthalmol; 2018 Mar; 62(2):186-193. PubMed ID: 29305715
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid.
Bhalla S; Joshi D; Bhullar S; Kasuga D; Park Y; Kay CN
Br J Ophthalmol; 2013 Jul; 97(7):895-9. PubMed ID: 23603755
[TBL] [Abstract][Full Text] [Related]
19. Threshold levels of visual field and acuity loss related to significant decreases in the quality of life and emotional states of patients with retinitis pigmentosa.
Azoulay L; Chaumet-Riffaud P; Jaron S; Roux C; Sancho S; Berdugo N; Audo I; Sahel JA; Mohand-Saïd S
Ophthalmic Res; 2015; 54(2):78-84. PubMed ID: 26228470
[TBL] [Abstract][Full Text] [Related]
20. Relationship between visual acuity and visual field and its reproducibility in patients with retinitis pigmentosa.
Asaoka R; Miyata M; Oishi A; Fujino Y; Murata H; Azuma K; Obata R; Inoue T
Eye (Lond); 2023 Apr; 37(6):1094-1099. PubMed ID: 35444265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
